(Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's diabetes and weight-loss drugs on ...

Shares of Hims & Hers Health (NYSE: HIMS) surged on Tuesday, closing the session up 5.25% after having been up by as much as ...

Two AI healthcare stocks -- Recursion Pharmaceuticals ( RXRX -2.76%) and Teladoc Health ( TDOC -5.20%) -- have lagged the ...

Despite the still positive FCF generation and richer balance sheet, it remains to be seen when Teladoc's growth may ...

The company’s stock rise reflects investor optimism following the news that Hims & Hers will provide both branded versions of ...

Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Hims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Here are five key ways cloud computing is revolutionising the healthcare industry, along with insights into how a few ...

Teladoc (TDOC) reachead $8.64 at the closing of the latest trading day, reflecting no change compared to its last close.

Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) have been assigned an average rating of “Hold” from the eighteen ...

Teladoc Health Inc. investors can’t proceed with a proposed class action alleging the online health company misrepresented ...